PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
67.17
-2.76 (-3.96%)
Feb 11, 2025, 11:52 AM EST - Market open
PROCEPT BioRobotics Revenue
PROCEPT BioRobotics had revenue of $58.37M in the quarter ending September 30, 2024, with 66.29% growth. This brings the company's revenue in the last twelve months to $199.84M, up 71.71% year-over-year. In the year 2023, PROCEPT BioRobotics had annual revenue of $136.19M with 81.55% growth.
Revenue (ttm)
$199.84M
Revenue Growth
+71.71%
P/S Ratio
17.91
Revenue / Employee
$319,238
Employees
626
Market Cap
3.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 136.19M | 61.18M | 81.55% |
Dec 31, 2022 | 75.01M | 40.54M | 117.60% |
Dec 31, 2021 | 34.47M | 26.76M | 346.72% |
Dec 31, 2020 | 7.72M | 1.55M | 25.09% |
Dec 31, 2019 | 6.17M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PRCT News
- 4 days ago - PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference - GlobeNewsWire
- 26 days ago - Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT) - Business Wire
- 2 months ago - PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024 - GlobeNewsWire
- 2 months ago - Procept BioRobotics: Continued Growth Runway Ahead - Seeking Alpha
- 3 months ago - PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock - GlobeNewsWire
- 3 months ago - PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock - GlobeNewsWire
- 3 months ago - Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential - Benzinga
- 3 months ago - PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript - Seeking Alpha